TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires dédié à aider les gens à voir avec clarté, a annoncé aujourd’hui l’approbation de la lentille intraoculaire (LIO) ClareonMD PanOptix MD Pro pour les…
Author: Business Wire
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
TORONTO–(BUSINESS WIRE)– #AlconCanada–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in Canada. Pa…
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+L…
Sling Therapeutics Appoints Ken Lock as Chief Commercial Officer
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics Appoints Ken Lock as Chief Commercial Officer
PolyActiva Appoints Jerry St. Peter as CEO and Secures $25M Series C Financing to Accelerate US Expansion and Clinical Advancement of PREZIA™ Technology Platform
MELBOURNE, Australia & FORT WORTH, Texas–(BUSINESS WIRE)–PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, today announced two major milestones …
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
NASHVILLE, Tenn.–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Mike Biega has joined Harrow as Vice President of Investor Relations and Communications, succeeding Jamie Webb, Dire…
Amaros Closes Series A Financing, Expands Advisory Board to Accelerate Market Entry of the EvidenceEngine™ Ophthalmic AI Platform
ATHERTON, Calif.–(BUSINESS WIRE)–Amaros Inc. (www.amaros.ai), a leader in ophthalmic intelligence and the developer of AI-powered EvidenceEngine platform, today announced the successful close of its Series A financing. Backed by a select group of new…
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune‑mediated and metabolic diseases, today announced the res…
Sightview Names Tycene Fritcher as CEO
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview, the only electronic health record and practice management partner focused solely on eyecare, has named Tycene Fritcher as CEO.
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a Single Agent
RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, fo…
HOYA Vision Care在2025年视觉与眼科研究协会(ARVO)年会上公布最新研究进展
盐湖城–(BUSINESS WIRE)–(美国商业资讯)– HOYA Vision Care (https://www.hoyavision.com/)今日公布了三项关键临床研究的新临床证据，凸显了多区正向光学离焦(D.I.M.S.)技术的效果。这些成果作为该公司2025年“通过MiYOSMART*探索近视管理新前沿”科学项目的一部分，在美国犹他州盐湖城举行的2025年视觉与眼科研究协会(ARVO)年会上呈报。 全球最长近视管理镜片临床研究的最新发现显示，在整整8年(n=11)的随访期内，持续…
HOYAビジョンケア、眼科と視覚に関する研究会議（ARVO）の2025年年次総会で最新情報を発表
ソルトレイクシティ–(BUSINESS WIRE)–（ビジネスワイヤ） — HOYAビジョンケア（https://www.hoyavision.com/）はDIMA技術の影響を浮き彫りにする3つの臨床試験から得られた新しいエビデンスを発表 しました。本結果は、ユタ州ソルトレイクシティで開催された2025年視覚と眼科学研究協会（ARVO）年次総会において、同社の2025年科学プログラム「MiYOSMART*による近視管理の新たなフロンティアの探求」の一環として発表されました。 近視管理用眼鏡レン…
HOYA Vision Care presenta gli aggiornamenti dal Convegno annuale della Association for Research in Vision and Ophthalmology (ARVO) 2025
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) oggi ha annunciato una nuova evidenza clinica proveniente da tre studi clinici chiave che evidenziano l’impatto della tecnologia D.I.M.S. (Defocus Incorporated Multiple Seg…
HOYA Vision Care dévoile les dernières nouvelles de la réunion annuelle 2025 de l'Association for Research in Vision and Ophthalmology (ARVO)
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) a annoncé aujourd’hui de nouvelles preuves cliniques issues de trois études cliniques clés soulignant l’impact de la technologie D.I.M.S. (Defocus Incorporated Multiple Seg…
HOYA Vision Care onthult updates van de jaarlijkse bijeenkomst van de Association for Research in Vision and Ophthalmology (ARVO) 2025
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) heeft vandaag nieuw klinisch bewijs aangekondigd uit drie belangrijke klinische studies die de impact van Defocus Incorporated Multiple Segments (D.I.M.S.)-technologie bena…
HOYA Vision Care presenta nuevos hallazgos en la reunión anual de 2025 de la Asociación de Investigación en Visión y Oftalmología (ARVO)
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) presentó hoy los nuevos resultados que arrojaron tres estudios clínicos clave y que destacan el impacto de la tecnología de lentes de desenfoque periférico (DIMS). Los resu…
HOYA Vision Care informiert über Neuigkeiten von dem Jahreskongress 2025 der Association for Research in Vision and Ophthalmology (ARVO)
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care ( https://www.hoyavision.com/) hat heute neue klinische Nachweise aus drei wichtigen klinischen Studien veröffentlicht, die die Wirkung der Defocus Incorporated Multiple Segments (D.I.M.S.)-Technologie …
HOYA Vision Care在2025年視覺與眼科研究協會(ARVO)年會上公布最新研究進展
鹽湖城–(BUSINESS WIRE)–(美國商業資訊)– HOYA Vision Care (https://www.hoyavision.com/)今日公布了三項關鍵臨床研究的新臨床證據，彰顯了多區正向光學離焦(D.I.M.S.)技術的效果。這些成果是該公司2025年「透過MiYOSMART*探索近視管理新尖端」科學計畫的一部分，在美國猶他州鹽湖城舉行的2025年視覺與眼科研究協會(ARVO)年會上呈報。 全球最長近視管理鏡片臨床研究的最新發現顯示，在整整8年(n=11)的隨訪期內，持續佩…
HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) today announced new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. The results w…
As mais recentes tecnologias cirúrgicas inovadoras da Alcon, o UNITY® VCS e o UNITY® CS, são aprovadas no Brasil
SÃO PAULO–(BUSINESS WIRE)– #Alcon–A Alcon, líder global em cuidados com a visão dedicada a ajudar as pessoas a verem de forma brilhante, anuncia que o equipamento para cirurgias de retina e vítreo e de catarata (VCS/CS) UNITY®, bem como o equipament…